Wearable Cancer Detection Tests 1-2% of Blood Over 2 Hours
Tests of a wearable cancer detection system are very positive. The system continuously collects CTCs directly from a peripheral vein. The system returns the remaining blood products after CTC enrichment, permitting testing of larger blood volumes than classic phlebotomy specimens over a prolonged period of time. The system is validated in canine models showing capability to screen 1–2% of the entire blood over 2 hours. This is about seven times more than a regular blood draw.